These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 12857715)

  • 1. Neurogenic atherosclerosis mediated by neuropeptide y: hardening of the evidence.
    Sobey CG
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1137-9. PubMed ID: 12857715
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuropeptide Y-induced acceleration of postangioplasty occlusion of rat carotid artery.
    Li L; Lee EW; Ji H; Zukowska Z
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1204-10. PubMed ID: 12689918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y: multiple receptors and multiple roles in cardiovascular diseases.
    Pons J; Lee EW; Li L; Kitlinska J
    Curr Opin Investig Drugs; 2004 Sep; 5(9):957-62. PubMed ID: 15503651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic stress induces rapid occlusion of angioplasty-injured rat carotid artery by activating neuropeptide Y and its Y1 receptors.
    Li L; Jönsson-Rylander AC; Abe K; Zukowska Z
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2075-80. PubMed ID: 16051880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent developments with neuropeptide Y receptor antagonists.
    Lundberg JM; Modin A; Malmström RE
    Trends Pharmacol Sci; 1996 Sep; 17(9):301-4. PubMed ID: 8885691
    [No Abstract]   [Full Text] [Related]  

  • 6. Blunted pancreatic polypeptide-induced vasodilatation in mesenteric resistance vessels from spontaneously hypertensive rats.
    Gradin KA; Li JY; Zhu H; Simonsen U
    Eur J Pharmacol; 2008 Dec; 601(1-3):118-23. PubMed ID: 18851959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adventitial progenitor cells contribute to arteriosclerosis.
    Torsney E; Hu Y; Xu Q
    Trends Cardiovasc Med; 2005 Feb; 15(2):64-8. PubMed ID: 15885572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization and appetite suppressive properties of BMS-193885, a novel and selective neuropeptide Y(1) receptor antagonist.
    Antal-Zimanyi I; Bruce MA; Leboulluec KL; Iben LG; Mattson GK; McGovern RT; Hogan JB; Leahy CL; Flowers SC; Stanley JA; Ortiz AA; Poindexter GS
    Eur J Pharmacol; 2008 Aug; 590(1-3):224-32. PubMed ID: 18573246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the pathogenesis of atherosclerosis.
    She M; Yu L
    Chin Med J (Engl); 1997 Jan; 110(1):14-21. PubMed ID: 9594315
    [No Abstract]   [Full Text] [Related]  

  • 10. Evidence for a role of macrophage migration inhibitory factor in vascular disease.
    Chen Z; Sakuma M; Zago AC; Zhang X; Shi C; Leng L; Mizue Y; Bucala R; Simon D
    Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):709-14. PubMed ID: 14751814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age.
    Dimitrijević M; Stanojević S; Mitić K; Kustrimović N; Vujić V; Miletić T; Kovacević-Jovanović V
    Peptides; 2008 Dec; 29(12):2179-87. PubMed ID: 18805447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5. Neuropeptide Y receptor antagonists in cardiovascular pharmacology.
    Malmström RE
    Prog Med Chem; 2004; 42():207-44. PubMed ID: 15003722
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuropeptide Y as a partial agonist of the Y1 receptor.
    Sah R; Balasubramaniam A; Parker MS; Sallee F; Parker SL
    Eur J Pharmacol; 2005 Nov; 525(1-3):60-8. PubMed ID: 16293244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An overview of neuropeptide Y: pharmacology to molecular biology and receptor localization.
    Dumont Y; Quirion R
    EXS; 2006; (95):7-33. PubMed ID: 16382995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in the pig coronary artery injury model: comparison of plain old balloon angioplasty and stent implantation].
    Shimizu N; Suzuki H; Wakabayashi K; Iso Y; Shibata M; Yorozuya M; Katagiri T; Takeyama Y
    J Cardiol; 2004 Mar; 43(3):131-9. PubMed ID: 15067801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling of neuropeptide receptors Y1, Y4, Y5, and docking studies with neuropeptide antagonist.
    Jois SD; Nagarajarao LM; Prabhakaran M; Balasubramaniam A
    J Biomol Struct Dyn; 2006 Apr; 23(5):497-508. PubMed ID: 16494499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of HGF gene enhances endothelial progenitor cell (EPC) function and improves EPC transplant efficiency for balloon-induced arterial injury in hypercholesterolemic rats.
    Song MB; Yu XJ; Zhu GX; Chen JF; Zhao G; Huang L
    Vascul Pharmacol; 2009; 51(2-3):205-13. PubMed ID: 19577663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor regulates reendothelialization and neointima formation in a mouse model of arterial injury.
    Hutter R; Carrick FE; Valdiviezo C; Wolinsky C; Rudge JS; Wiegand SJ; Fuster V; Badimon JJ; Sauter BV
    Circulation; 2004 Oct; 110(16):2430-5. PubMed ID: 15477421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
    Tu B; Jiao Y; Herzog H; Nadler JV
    Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.